Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Express Scripts
Accenture
Queensland Health
Baxter
Dow
Moodys
Fish and Richardson
McKinsey

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011418

« Back to Dashboard

NDA 011418 describes DIMETANE-TEN, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the DIMETANE-TEN profile page.

The generic ingredient in DIMETANE-TEN is brompheniramine maleate. There are twenty-one drug master file entries for this compound. Additional details are available on the brompheniramine maleate profile page.
Summary for 011418
Tradename:DIMETANE-TEN
Applicant:Wyeth Ayerst
Ingredient:brompheniramine maleate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 011418

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
McKinsey
Dow
Citi
Covington
Federal Trade Commission
AstraZeneca
Merck
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot